Cargando…

Comparative Immune Response after Vaccination with SOBERANA(®) 02 and SOBERANA(®) plus Heterologous Scheme and Natural Infection in Young Children

(1) Background: In children, SARS-CoV-2 infection is mostly accompanied by mild COVID-19 symptoms. However, multisystem inflammatory syndrome (MIS-C) and long-term sequelae are often severe complications. Therefore, the protection of the pediatric population against SARS-CoV-2 with effective vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez-Nicado, Rocmira, Massa, Chiara, Rodríguez-Noda, Laura Marta, Müller, Anja, Puga-Gómez, Rinaldo, Ricardo-Delgado, Yariset, Paredes-Moreno, Beatriz, Rodríguez-González, Meiby, García-Ferrer, Marylé, Palmero-Álvarez, Ilianet, Garcés-Hechavarría, Aniurka, Rivera, Daniel G., Valdés-Balbín, Yury, Vérez-Bencomo, Vicente, García-Rivera, Dagmar, Seliger, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675375/ https://www.ncbi.nlm.nih.gov/pubmed/38005968 http://dx.doi.org/10.3390/vaccines11111636

Ejemplares similares

Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
por: Toledo-Romani, María Eugenia, et al.
Publicado: (2022)

Soberana juventud
por: Maples Arce, Manuel, 1900-1981
Publicado: (1967)

Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial
por: Toledo-Romaní, María Eugenia, et al.
Publicado: (2022)

Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials
por: Eugenia-Toledo-Romaní, María, et al.
Publicado: (2022)

Soberana juventud : (Memorias II)
por: Maples Arce, Manuel, 1900-1981
Publicado: (2010)

Soberana juventud: Memorias II
por: Maples Arce, Manuel
Publicado: (2020)

Razón soberana : y otros estudios de filosofía de la ciencia
por: Nagel, Ernest, 1901-
Publicado: (1966)

Europa, deudas soberanas y financiarización
por: Girón, Alicia
Publicado: (2013)

La Soberana Convención Revoluciónaria, 1914-1916
por: Amaya C., Luis Fernando
Publicado: (1966)

La Soberana Convención Revolucionaria, 1914-1916 /
por: Amaya C, Luis Fernando
Publicado: (1989)

Soberana convención revolucionaria, 1914-1915 : Alberto Enríquez Perea, coordinador.
Publicado: (2018)

La Soberana Convención Revolucionaria en Aguascalientes : 1914-1989.
Publicado: (1990)

La Soberana Convención Revolucionaria en Aguascalientes : 1914-1989.
Publicado: (1990)

La soberana del campo de oro ; El rey de los cangrejos /
por: Salgari, Emilio, 1862-1911
Publicado: (1991)

Soberana presencia de la patria y otros poemas
por: Moran Garay, Diana Elsa
Publicado: (1989)

Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein
por: Pouriayevali, Mohammad Hassan, et al.
Publicado: (2022)

Corrigendum to “Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein” [Vaccine 40(20) (2022) 2856–2868]
por: Pouriayevali, Mohammad Hassan, et al.
Publicado: (2022)

Crónicas y debates de las sesiones de la Soberana Convención Revolucionaria /
Publicado: (1964)

Comparison of the Onset and End of Specific and Major Side Effects in Iranian Teenage Participants Vaccinated With COVID-19 Vaccine: Sinopharm and Soberana
por: Tavakoli, Nader, et al.
Publicado: (2023)

Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children
por: Puga-Gómez, Rinaldo, et al.
Publicado: (2023)

Self-assembled particulate PsaA as vaccine against Streptococcus pneumoniae infection
por: González-Miro, Majela, et al.
Publicado: (2017)

A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity
por: Pérez-Rodríguez, Sonia, et al.
Publicado: (2022)

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial
por: Chang-Monteagudo, Arturo, et al.
Publicado: (2021)

Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines
por: Valdes-Balbin, Yury, et al.
Publicado: (2021)

Reinas : cinco soberanas y sus biografías /
por: Gottschalk, Maren
Publicado: (2010)

Bioengineered polyester beads co-displaying protein and carbohydrate-based antigens induce protective immunity against bacterial infection
por: González-Miró, Majela, et al.
Publicado: (2018)

Multicomponent polysaccharide–protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates
por: Méndez, Yanira, et al.
Publicado: (2018)

A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles
por: Santana-Mederos, Darielys, et al.
Publicado: (2021)

Glycan Array Evaluation of Synthetic Epitopes between the Capsular Polysaccharides from Streptococcus pneumoniae 19F and 19A
por: Morelli, Laura, et al.
Publicado: (2021)

Repeat-dose and local tolerance toxicity of SARS-CoV-2 FINLAY-FR-02 vaccine candidate in Sprague Dawley rats
por: Oliva-Hernández, Reynaldo, et al.
Publicado: (2022)

Synthetic, Zwitterionic Sp1 Oligosaccharides Adopt a Helical Structure Crucial for Antibody Interaction
por: Zhang, Qingju, et al.
Publicado: (2019)

La Corte Penal Internacional : la cuestión humana versus razón soberana /
por: Trujillo Sánchez, Aníbal
Publicado: (2011)

Immunogenicity and safety of heterologous boost immunization with PastoCovac Plus against COVID-19 in ChAdOx1-S or BBIBP-CorV primed individuals
por: Eybpoosh, Sana, et al.
Publicado: (2023)

Elecciones a gobernador del estado de Veracruz en el año 2004, un proceso electoral desigual/
por: Amaro Amaro, Yariset
Publicado: (2013)

Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial
por: Ochoa-Azze, Rolando, et al.
Publicado: (2022)

Assessing the immunogenicity and toxicity of the AFPL1-conjugate nicotine vaccine using heterologous and homologous vaccination routes
por: Fraleigh, Nya L., et al.
Publicado: (2019)

Expression of Lectins in Heterologous Systems
por: Martínez-Alarcón, Dania, et al.
Publicado: (2018)

Brief telephone intervention for caregivers of medically complex patients during COVID-19
por: Stevens-Carr, Mary, et al.
Publicado: (2020)

Strategies for Heterologous Expression, Synthesis, and Purification of Animal Venom Toxins
por: Rivera-de-Torre, Esperanza, et al.
Publicado: (2022)

The Dark Side of Dendritic Cells: Development and Exploitation of Tolerogenic Activity That Favor Tumor Outgrowth and Immune Escape
por: Seliger, Barbara, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2ovmiploqngnd16mpeuiror635